<DOC>
	<DOCNO>NCT02093104</DOCNO>
	<brief_summary>The purpose research study evaluate quantitative information utilize C-arm system liver tumor care hop potential clinical combination imaging could aid diagnosis evaluation tumor therapy .</brief_summary>
	<brief_title>TACE Study-Liver Embolization Perfusion ( VGH Radiology LIU )</brief_title>
	<detailed_description>Blood flow image liver tumor normally carry use clinical Computed Tomography ( CT ) Magnetic Resonance Imaging ( MRI ) system prior go cath lab . This study aim determine measure flow use C-arm system and/or CT perfusion use improve diagnosis evaluation liver tumor . The major difference C-arm CT system clinical CT system difference image speed . We develop new approach allow u overcome speed limitation . The major difference conventional CT versus CT perfusion obtain extra series image . CT perfusion result increase amount radiation exposure CT scan measure blood flow target tumor ; however , CT perfusion much faster conventional CT . Prospective participant invite study part treatment towards tumour therapy involve obtain angiogram .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>1 . Histological cytological diagnosis meet AASLD criterion diagnosis hepatocellular carcinoma ( HCC ) least one unidimensional lesion measurable accord Response Evaluation Criteria Solid Tumors ( RECIST ) criterion CTscan 2 . OR radiologic evidence liver metastatic disease 3 . Amenable embolization ablation adjuvant , neoadjuvant definitive ( curative palliative ) therapy . 4 . Adult &gt; 19 year old estimate life expectancy 3 month 5 . Eastern Cooperative Oncology Group ( ECOG ) performance status equal 1 6 . Adequate haematological function : Hb equal 9g/100mL , absolute neutrophil count equal 1 500/mm3 , platelet count equal 50 000/mm3 7 . Adequate renal function ; serum creatinine 150μmol/L 8 . Bilirubin equal 50 µmol/L , Aspartate aminotransferase ( AST ) ALT uner equal 5 x upper limit normal ( ULN ) , international normalize ratio ( INR ) equal 1.5 9 . Liver cirrhosis Child Pugh A B7 10 . Ability provide write informed consent 1 . Advanced liver disease ChildPugh score 7 active gastrointestinal bleeding encephalopathy ascites refractory diuretic therapy 2 . Women pregnant breast feed 3 . Allergy contrast medium 4 . Contraindication hepatic artery catheterisation , severe peripheral vascular disease preclude catheterisation OR contraindication locally curative ablation due size , location shape . 5 . Psychiatric disorder likely impact inform consent 6 . Patient unable and/or unwilling comply treatment study instruction</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>unresectable hepatocellular carcinoma</keyword>
	<keyword>( undergo chemoembolization radioembolization )</keyword>
</DOC>